$SNES
SenesTech, Inc. Stock $snes

$snes Overview Financials Valuation SEC Filings Company Website

2023 Q3 Form 10-Q Financial Statement

#000162828023028937 Filed on August 11, 2023

Income Statement

Concept	2023 Q3	2023 Q2
Revenue	$360.0K	$305.0K
YoY Change	44.0%	10.11%
Cost Of Revenue	$184.0K	$163.0K
YoY Change	43.75%	15.6%
Gross Profit	$176.0K	$142.0K
YoY Change	44.26%	4.41%
Gross Profit Margin	48.89%	46.56%
Selling, General & Admin	$1.748M	$1.761M
YoY Change	-23.63%	-22.66%
% of Gross Profit	993.18%	1240.14%
Research & Development	$379.0K	$381.0K
YoY Change	-16.15%	-11.6%
% of Gross Profit	215.34%	268.31%
Depreciation & Amortization	$34.00K	$33.00K
YoY Change	-2.86%	-29.79%
% of Gross Profit	19.32%	23.24%
Operating Expenses	$2.127M	$2.142M
YoY Change	-22.4%	-20.9%
Operating Profit	-$1.951M	-$2.000M
YoY Change	-25.51%	-22.24%
Interest Expense	$4.000K	$7.000K
YoY Change	300.0%	600.0%
% of Operating Profit
Other Income/Expense, Net	$4.000K	$7.000K
YoY Change	-114.81%	133.33%
Pretax Income	-$1.947M	-$1.993M
YoY Change	-26.42%	-22.42%
Income Tax
% Of Pretax Income
Net Earnings	-$1.947M	-$1.993M
YoY Change	-26.42%	-22.42%
Net Earnings / Revenue	-540.83%	-653.44%
Basic Earnings Per Share	-$0.47	-$0.70
Diluted Earnings Per Share	-$0.47	-$0.70
COMMON SHARES
Basic Shares Outstanding	2.964M shares	2.861M shares
Diluted Shares Outstanding	4.177M shares	2.861M shares

Balance Sheet

Concept	2023 Q3	2023 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$2.145M	$2.196M
YoY Change	-23.17%	-56.08%
Cash & Equivalents	$2.100M	$2.200M
Short-Term Investments
Other Short-Term Assets	$385.0K	$330.0K
YoY Change	-9.62%	-8.33%
Inventory	$703.0K	$765.0K
Prepaid Expenses	$385.0K	$330.0K
Receivables	$83.00K	$44.00K
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$3.316M	$3.335M
YoY Change	-22.14%	-48.05%
LONG-TERM ASSETS
Property, Plant & Equipment	$313.0K	$245.0K
YoY Change	-2.8%	-33.24%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$22.00K	$22.00K
YoY Change
Total Long-Term Assets	$552.0K	$528.0K
YoY Change	-22.36%	-33.83%
TOTAL ASSETS
Total Short-Term Assets	$3.316M	$3.335M
Total Long-Term Assets	$552.0K	$528.0K
Total Assets	$3.868M	$3.863M
YoY Change	-22.17%	-46.48%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$147.0K	$120.0K
YoY Change	-69.12%	-58.04%
Accrued Expenses	$671.0K	$621.0K
YoY Change	-32.02%	-29.75%
Deferred Revenue	$15.00K	$24.00K
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due	$9.000K
YoY Change
Total Short-Term Liabilities	$1.034M	$953.0K
YoY Change	-31.57%	-21.3%
LONG-TERM LIABILITIES
Long-Term Debt	$44.00K	$0.00
YoY Change
Other Long-Term Liabilities	$34.00K	$83.00K
YoY Change	-91.54%	-81.26%
Total Long-Term Liabilities	$78.00K	$83.00K
YoY Change	-80.6%	-81.26%
TOTAL LIABILITIES
Total Short-Term Liabilities	$1.034M	$953.0K
Total Long-Term Liabilities	$78.00K	$83.00K
Total Liabilities	$1.112M	$1.036M
YoY Change	-41.87%	-37.36%
SHAREHOLDERS EQUITY
Retained Earnings	-$128.2M	-$126.2M
YoY Change	6.78%	7.49%
Common Stock	$3.000K	$3.000K
YoY Change	-75.0%	-75.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$2.756M	$2.827M
YoY Change
Total Liabilities & Shareholders Equity	$3.868M	$3.863M
YoY Change	-22.17%	-46.48%

Cashflow Statement

Concept	2023 Q3	2023 Q2
OPERATING ACTIVITIES
Net Income	-$1.947M	-$1.993M
YoY Change	-26.42%	-22.42%
Depreciation, Depletion And Amortization	$34.00K	$33.00K
YoY Change	-2.86%	-29.79%
Cash From Operating Activities	-$1.787M	-$1.742M
YoY Change	-19.47%	-17.79%
INVESTING ACTIVITIES
Capital Expenditures	$94.00K	$20.00K
YoY Change	754.55%	-125.0%
Acquisitions
YoY Change
Other Investing Activities	$0.00
YoY Change
Cash From Investing Activities	-$94.00K	-$20.00K
YoY Change	-954.55%	-75.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	1.831M	1.210M
YoY Change		-7662.5%
NET CHANGE
Cash From Operating Activities	-1.787M	-1.742M
Cash From Investing Activities	-94.00K	-20.00K
Cash From Financing Activities	1.831M	1.210M
Net Change In Cash	-50.00K	-552.0K
YoY Change	-97.74%	-75.08%
FREE CASH FLOW
Cash From Operating Activities	-$1.787M	-$1.742M
Capital Expenditures	$94.00K	$20.00K
Free Cash Flow	-$1.881M	-$1.762M
YoY Change	-15.65%	-13.59%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022Q2	us-gaap	Investment Income Net InvestmentIncomeNet	1000	usd
CY2023Q2	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	24000	usd
CY2022Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	44000	usd
CY2023Q2	us-gaap	Liabilities Current LiabilitiesCurrent	953000	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	1324000	usd
CY2023Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	83000	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	179000	usd
CY2023Q2	us-gaap	Liabilities Liabilities	1036000	usd
CY2022Q4	us-gaap	Liabilities Liabilities	1503000	usd
CY2023Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2023Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2023Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2023Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2023Q2	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2022Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2023Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2023Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	2964485	shares
CY2023Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	2964485	shares
CY2023Q2	us-gaap	Common Stock Value CommonStockValue	3000	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	1000	usd
CY2023Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	129057000	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	127481000	usd
CY2023Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-126233000	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-122203000	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	2827000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	5279000	usd
CY2023Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	3863000	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	6782000	usd
CY2023Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	305000	usd
CY2022Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	277000	usd
CY2023Q2	us-gaap	Gross Profit GrossProfit	142000	usd
CY2022Q2	us-gaap	Gross Profit GrossProfit	136000	usd
CY2023Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	381000	usd
CY2022Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	431000	usd
CY2023Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1761000	usd
CY2022Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2277000	usd
CY2023Q2	us-gaap	Operating Expenses OperatingExpenses	2142000	usd
CY2022Q2	us-gaap	Operating Expenses OperatingExpenses	2708000	usd
CY2023Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-2000000	usd
CY2023Q2	us-gaap	Interest Expense Debt InterestExpenseDebt	0	usd
CY2022Q2	us-gaap	Interest Expense Debt InterestExpenseDebt	0	usd
CY2023Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	0	usd
CY2022Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	2000	usd
CY2023Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	7000	usd
CY2022Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	3000	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-1993000	usd
CY2023Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-1993000	usd
CY2022Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-2569000	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-2569000	usd
CY2023Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	2860874	shares
CY2023Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	2860874	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	610543	shares
CY2023Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.70
CY2023Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.70
CY2022Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-4.21
CY2022Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-4.21
	us-gaap	Net Income Loss NetIncomeLoss	-4030000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-4901000	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	69000	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	113000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	336000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	430000	usd
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	-2000	usd
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	12000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-71000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	19000	usd
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	2000	usd
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	0	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-420000	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-47000	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	61000	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	306000	usd
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-20000	usd
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	41000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-3757000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-4148000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	21000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	146000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-21000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-146000	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	1210000	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	0	usd
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	0	usd
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	5000	usd
	snes	Repayments Of Finance Lease Obligations RepaymentsOfFinanceLeaseObligations	0	usd
	snes	Repayments Of Finance Lease Obligations RepaymentsOfFinanceLeaseObligations	27000	usd
	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	11000	usd
	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	0	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1199000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-32000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-2579000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-4326000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	4775000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	9326000	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2196000	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	5000000	usd
	us-gaap	Interest Paid Net InterestPaidNet	0	usd
	us-gaap	Interest Paid Net InterestPaidNet	1000	usd
	us-gaap	Income Taxes Paid IncomeTaxesPaid	0	usd
	us-gaap	Income Taxes Paid IncomeTaxesPaid	0	usd
CY2023Q2	snes	Number Of States Registration Received NumberOfStatesRegistrationReceived	50	state
CY2023Q2	snes	Number Of States Approved Removal Of Restricted Use Designation NumberOfStatesApprovedRemovalOfRestrictedUseDesignation	49	state
CY2023Q2	snes	Number Of Major Us Territories Registration Received NumberOfMajorUSTerritoriesRegistrationReceived	5	territory
CY2023Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-126200000	usd
CY2023Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2200000	usd
	us-gaap	Use Of Estimates UseOfEstimates	<div style="margin-top:12pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts and classification of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements and reported amounts of revenues and expenses during the reporting period. The significant estimates in our financial statements include the valuation of inventory, common stock warrants, and stock-based awards, such as stock options and restricted stock units. Actual results could differ from such estimates.</span></div>
CY2023Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2200000	usd
CY2023Q2	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	48000	usd
CY2022Q4	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	119000	usd
CY2023Q2	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	4000	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	6000	usd
CY2023Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	44000	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	113000	usd
CY2023Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	4000	usd
CY2022Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	0	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	6000	usd
CY2021Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	0	usd
CY2023Q2	us-gaap	Allowance For Doubtful Accounts Receivable Period Increase Decrease AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease	0	usd
CY2022Q2	us-gaap	Allowance For Doubtful Accounts Receivable Period Increase Decrease AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease	12000	usd
	us-gaap	Allowance For Doubtful Accounts Receivable Period Increase Decrease AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease	0	usd
	us-gaap	Allowance For Doubtful Accounts Receivable Period Increase Decrease AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease	12000	usd
CY2023Q2	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	0	usd
CY2022Q2	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	0	usd
	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	2000	usd
	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	0	usd
CY2023Q2	us-gaap	Inventory Raw Materials InventoryRawMaterials	729000	usd
CY2022Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	772000	usd
CY2023Q2	us-gaap	Inventory Finished Goods InventoryFinishedGoods	54000	usd
CY2022Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	99000	usd
CY2023Q2	us-gaap	Inventory Gross InventoryGross	783000	usd
CY2022Q4	us-gaap	Inventory Gross InventoryGross	871000	usd
CY2023Q2	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	18000	usd
CY2022Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	18000	usd
CY2023Q2	us-gaap	Inventory Net InventoryNet	765000	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	853000	usd
CY2023Q1	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	18000	usd
CY2022Q1	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	26000	usd
CY2022Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	18000	usd
CY2021Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	29000	usd
CY2023Q2	snes	Inventory Valuation Reserves Additions InventoryValuationReservesAdditions	0	usd
CY2022Q2	snes	Inventory Valuation Reserves Additions InventoryValuationReservesAdditions	0	usd
	snes	Inventory Valuation Reserves Additions InventoryValuationReservesAdditions	0	usd
	snes	Inventory Valuation Reserves Additions InventoryValuationReservesAdditions	0	usd
CY2023Q2	snes	Inventory Valuation Reserves Amount Relieved InventoryValuationReservesAmountRelieved	0	usd
CY2022Q2	snes	Inventory Valuation Reserves Amount Relieved InventoryValuationReservesAmountRelieved	4000	usd
	snes	Inventory Valuation Reserves Amount Relieved InventoryValuationReservesAmountRelieved	0	usd
	snes	Inventory Valuation Reserves Amount Relieved InventoryValuationReservesAmountRelieved	7000	usd
CY2023Q2	snes	Professional Services Retainer ProfessionalServicesRetainer	107000	usd
CY2022Q4	snes	Professional Services Retainer ProfessionalServicesRetainer	41000	usd
CY2023Q2	us-gaap	Prepaid Insurance PrepaidInsurance	97000	usd
CY2022Q4	us-gaap	Prepaid Insurance PrepaidInsurance	61000	usd
CY2023Q2	snes	Prepaid Software Licenses Current PrepaidSoftwareLicensesCurrent	94000	usd
CY2022Q4	snes	Prepaid Software Licenses Current PrepaidSoftwareLicensesCurrent	157000	usd
CY2023Q2	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	14000	usd
CY2022Q4	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	6000	usd
CY2023Q2	us-gaap	Finite Lived Patents Gross FiniteLivedPatentsGross	10000	usd
CY2022Q4	us-gaap	Finite Lived Patents Gross FiniteLivedPatentsGross	39000	usd
CY2023Q2	snes	Marketing Programs And Conferences MarketingProgramsAndConferences	8000	usd
CY2022Q4	snes	Marketing Programs And Conferences MarketingProgramsAndConferences	74000	usd
CY2023Q2	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	330000	usd
CY2022Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	378000	usd
CY2023Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	2353000	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	2283000	usd
CY2023Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	245000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	294000	usd
CY2023Q2	us-gaap	Accrued Employee Benefits Current AccruedEmployeeBenefitsCurrent	468000	usd
CY2022Q4	us-gaap	Accrued Employee Benefits Current AccruedEmployeeBenefitsCurrent	497000	usd
CY2023Q2	snes	Legal Services Current LegalServicesCurrent	138000	usd
CY2022Q4	snes	Legal Services Current LegalServicesCurrent	36000	usd
CY2023Q2	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	15000	usd
CY2022Q4	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	18000	usd
CY2023Q2	snes	Personal Property And Franchise Tax PersonalPropertyAndFranchiseTax	0	usd
CY2022Q4	snes	Personal Property And Franchise Tax PersonalPropertyAndFranchiseTax	6000	usd
CY2023Q2	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	0	usd
CY2022Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	3000	usd
CY2023Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	621000	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	560000	usd
CY2023Q2	us-gaap	Operating Lease Cost OperatingLeaseCost	55000	usd
CY2022Q2	us-gaap	Operating Lease Cost OperatingLeaseCost	56000	usd
	us-gaap	Operating Lease Cost OperatingLeaseCost	111000	usd
	us-gaap	Operating Lease Cost OperatingLeaseCost	112000	usd
CY2023Q2	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	0	usd
CY2022Q2	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	11000	usd
	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	0	usd
	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	27000	usd
CY2023Q2	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	0	usd
CY2022Q2	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	0	usd
	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	0	usd
	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	1000	usd
CY2023Q2	snes	Finance Lease Cost FinanceLeaseCost	0	usd
CY2022Q2	snes	Finance Lease Cost FinanceLeaseCost	11000	usd
	snes	Finance Lease Cost FinanceLeaseCost	0	usd
	snes	Finance Lease Cost FinanceLeaseCost	28000	usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	99000	usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	186000	usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	285000	usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	14000	usd
CY2023Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	271000	usd
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	280448	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	17.11
CY2023Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P4Y4M24D
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	199421	shares
CY2023Q2	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	1.25
CY2023Q2	snes	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Remaining Contractual Term ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageRemainingContractualTerm	P5Y
CY2023Q2	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	0	shares
CY2023Q2	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	107	shares
CY2023Q2	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	39.64
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	336	shares
CY2023Q2	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice	118.25
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	479426	shares
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	10.01
CY2023Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P4Y6M
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	280810	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	17.00
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P3Y10M24D
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	199421	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	1.25
	snes	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Remaining Contractual Term ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageRemainingContractualTerm	P5Y
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	0	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	433	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	119.46
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	372	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice	680.87
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	479426	shares
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	10.01
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P4Y6M
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	139583	shares
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	29.16
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P3Y9M18D
CY2023Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	170000	usd
CY2022Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	206000	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	336000	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	430000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	5279000	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	166000	usd
CY2023Q1	snes	Stock Issued During Period Value Warrants Exercised StockIssuedDuringPeriodValueWarrantsExercised	0	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	100000	usd
CY2023Q1	us-gaap	Restricted Stock Value Shares Issued Net Of Tax Withholdings RestrictedStockValueSharesIssuedNetOfTaxWithholdings	-11000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-2037000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	3497000	usd
CY2023Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	113000	usd
CY2023Q2	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	1210000	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-1993000	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	2827000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	10035000	usd
CY2022Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	221000	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	3000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-2332000	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	7927000	usd
CY2022Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	205000	usd
CY2022Q2	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	1000	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-2569000	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	5564000	usd
	us-gaap	Stock Issued During Period Shares Issued For Services StockIssuedDuringPeriodSharesIssuedForServices	54466	shares
	us-gaap	Restricted Stock Shares Issued Net Of Shares For Tax Withholdings RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings	13225	shares
CY2022Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	4414810	shares
CY2022Q4	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	6.58
CY2022	snes	Class Of Warrant Or Right Outstanding Weighted Average Remaining Contractual Term ClassOfWarrantOrRightOutstandingWeightedAverageRemainingContractualTerm	P3Y
	snes	Class Of Warrant Or Right Issued ClassOfWarrantOrRightIssued	921432	shares
CY2023Q2	snes	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights Issued ClassOfWarrantOrRightExercisePriceOfWarrantsOrRightsIssued	1.66
	snes	Class Of Warrant Or Right Issued Weighted Average Remaining Contractual Term ClassOfWarrantOrRightIssuedWeightedAverageRemainingContractualTerm	P5Y3M18D
	snes	Class Of Warrant Or Right Exercised ClassOfWarrantOrRightExercised	1230000	shares
CY2023Q2	snes	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights Exercised ClassOfWarrantOrRightExercisePriceOfWarrantsOrRightsExercised	3.50
	snes	Class Of Warrant Or Right Expired ClassOfWarrantOrRightExpired	2835	shares
CY2023Q2	snes	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights Expired ClassOfWarrantOrRightExercisePriceOfWarrantsOrRightsExpired	728.00
CY2023Q2	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	4103407	shares
CY2023Q2	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	5.91
	snes	Class Of Warrant Or Right Outstanding Weighted Average Remaining Contractual Term ClassOfWarrantOrRightOutstandingWeightedAverageRemainingContractualTerm	P3Y2M12D
CY2023Q2	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	10171	shares
CY2022Q2	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	0	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	242127	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	0	shares
CY2023Q2	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2023Q2	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2023Q2	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2023Q2	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false

Files In Submission

Name	View Source	Status
0001628280-23-028937-index-headers.html	Edgar Link	pending
0001628280-23-028937-index.html	Edgar Link	pending
0001628280-23-028937.txt	Edgar Link	pending
0001628280-23-028937-xbrl.zip	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
snes-20230630.htm	Edgar Link	pending
snes-20230630.xsd	Edgar Link	pending
snes-20230630xex311.htm	Edgar Link	pending
snes-20230630xex312.htm	Edgar Link	pending
snes-20230630xex321.htm	Edgar Link	pending
snes-20230630xex322.htm	Edgar Link	pending
snes-20230630_def.xml	Edgar Link	unprocessable
snes-20230630_lab.xml	Edgar Link	unprocessable
snes-20230630_pre.xml	Edgar Link	unprocessable
snes-20230630_htm.xml	Edgar Link	completed
snes-20230630_cal.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$SNES
SenesTech, Inc. Stock $snes

2023 Q3 Form 10-Q Financial Statement

#000162828023028937 Filed on August 11, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SNES SenesTech, Inc. Stock $snes

2023 Q3 Form 10-Q Financial Statement

#000162828023028937 Filed on August 11, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SNES
SenesTech, Inc. Stock $snes